Literature DB >> 26227530

Complete removal of infected devices and simultaneous implantation of new devices for infective endocarditis after pacemaker implantation.

Takuya Miura1, Kazushige Inoue2, Takenori Yokota2, Takashi Iwata2, Masao Yoshitatsu2.   

Abstract

Two cases of infective endocarditis after pacemaker implantation were reported. Complete removal of infected devices was performed under cardiopulmonary bypass, and simultaneous implantation of new devices was performed using epicardial leads and generator on the abdominal wall. The postoperative course was uneventful and recurrence was not recognized. These procedures may be suitable for the patients who depend on the pacemaker or who have repeat bacteremia with other infectious disease or conditions.

Entities:  

Keywords:  Cardiopulmonary bypass; Epicardial lead; Infective endocarditis; Pacemaker implantation

Mesh：

Year:  2015        PMID： 26227530     DOI： 10.1007/s11748-015-0577-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN： 1863-6705


  8 in total

1.  Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).

Authors:  Bruce L Wilkoff; Charles J Love; Charles L Byrd; Maria Grazia Bongiorni; Roger G Carrillo; George H Crossley; Laurence M Epstein; Richard A Friedman; Charles E H Kennergren; Przemyslaw Mitkowski; Raymond H M Schaerf; Oussama M Wazni
Journal:  Heart Rhythm       Date:  2009-05-22       Impact factor: 6.343

2.  Complete removal as a routine treatment for any cardiovascular implantable electronic device-associated infection.

Authors:  Maximilian Pichlmaier; Ludmilla Knigina; Ingo Kutschka; Christoph Bara; Hanno Oswald; Gunnar Klein; Theodosius Bisdas; Axel Haverich
Journal:  J Thorac Cardiovasc Surg       Date:  2011-05-12       Impact factor: 5.209

3.  Cardiac device-related endocarditis: 31-Years' experience.

Authors:  Damirbek Osmonov; Kazim Serhan Ozcan; Izzet Erdinler; Servet Altay; Ersin Yildirim; Ceyhan Turkkan; Ahmet Ekmekci; Baris Gungor; Kadir Gurkan
Journal:  J Cardiol       Date:  2012-11-17       Impact factor: 3.159

4.  Percutaneous lead implantation connected to an external device in stimulation-dependent patients with systemic infection--a prospective and controlled study.

Authors:  Martin U Braun; Thomas Rauwolf; Mania Bock; Utz Kappert; Alessandra Boscheri; Andreas Schnabel; Ruth H Strasser
Journal:  Pacing Clin Electrophysiol       Date:  2006-08       Impact factor: 1.976

5.  Risk factor analysis of permanent pacemaker infection.

Authors:  Muhammad R Sohail; Daniel Z Uslan; Akbar H Khan; Paul A Friedman; David L Hayes; Walter R Wilson; James M Steckelberg; Sarah M Stoner; Larry M Baddour
Journal:  Clin Infect Dis       Date:  2007-06-06       Impact factor: 9.079

6.  Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome.

Authors:  Ana del Río; Ignasi Anguera; José M Miró; Lluis Mont; Vance G Fowler; Manel Azqueta; Carlos A Mestres
Journal:  Chest       Date:  2003-10       Impact factor: 9.410

7.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.

Authors:  Muhammad R Sohail; Daniel Z Uslan; Akbar H Khan; Paul A Friedman; David L Hayes; Walter R Wilson; James M Steckelberg; Sarah Stoner; Larry M Baddour
Journal:  J Am Coll Cardiol       Date:  2007-04-23       Impact factor: 24.094

8.  Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.

Authors:  Gilbert Habib; Bruno Hoen; Pilar Tornos; Franck Thuny; Bernard Prendergast; Isidre Vilacosta; Philippe Moreillon; Manuel de Jesus Antunes; Ulf Thilen; John Lekakis; Maria Lengyel; Ludwig Müller; Christoph K Naber; Petros Nihoyannopoulos; Anton Moritz; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.